Mallinckrodt and Endo plan merger as they look to recover from opioid litigation

1 month ago 7
ARTICLE AD BOX
The new entity will be listed on the New York Stock Exchange and is expected to generate pro forma revenue of $3.6 billion in 2025 and at least $150 million of annual operating synergies by year three.
Read Entire Article
  1. Homepage
  2. Finance
  3. Mallinckrodt and Endo plan merger as they look to recover from opioid litigation

Related

Sam Altman's Eye-Scanning Orb Is Now Coming to the US

Sam Altman's Eye-Scanning Orb Is Now Coming to the US

3 hours ago 1
Tesla’s board reportedly initiated CEO search for Elon Musk’s successor

Tesla’s board reportedly initiated CEO search for Elon Musk’...

3 hours ago 0
Court upholds limits to DOGE access to Social Security data

Court upholds limits to DOGE access to Social Security data

5 hours ago 1

Trending

1. pg&e
2. lucas bravo
3. countdown amazon prime
4. ucla
5. kenny smith
6. steph curry thumb
7. bryce james
8. nick wright
9. lebron retiring
10. nba playoff bracket

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

2 months ago 160
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

2 months ago 125
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

2 months ago 124
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

2 months ago 116
Metal Gear Solid Delta: Snake Eater release date leaks on the PlayStation Store

Metal Gear Solid Delta: Snake Eater release date leaks on th...

2 months ago 110
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved